| Naziv: | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents |
Autori: | Beljkaš, Milan   ; Ružić, Dušan ; Djurić, Ana ; Vuletić, Ana ; Nchugoua Tchiehe, Guilaine; Jallet, Corinne; Cadet-Daniel, Veronique; Arimondo, Paola B; Santibanez, Juan F. ; Srdić-Rajić, Tatjana ;
|
Godina: | 2025 |
Publikacija: | Future Medicinal Chemistry |
ISSN: | 1756-8919 Future Medicinal Chemistry Pretraži identifikator |
Izdavač: | Taylor& Francis |
Tip rezultata: | Naučni članak |
Kolacija: | vol. 17 br. 4 str. 393-407 |
DOI: | 10.1080/17568919.2025.2459589 |
WoS-ID: | 001410279600001 |
Scopus-ID: | 2-s2.0-85216692820 |
PMID: | 39885716 |
PMCID: | PMC11834526 |
URI: | https://farfar.pharmacy.bg.ac.rs/handle/123456789/6344
https://enauka.gov.rs/handle/123456789/967387 |
URL: | https://www.tandfonline.com/doi/abs/10.1080/17568919.2025.2459589
https://pubmed.ncbi.nlm.nih.gov/39885716/ |
Projekat: | Ministry of Science, Technological Development and Innovation, Republic of Serbia
University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]
Ministry of Science, Technological Development and Innovation, Republic of Serbia
University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]
Ministry of Science, Technological Development and Innovation, Republic of Serbia
Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043] |
M-kategorija: | 22M22 - Međunarodni časopis kategorije M22 |
